2021
DOI: 10.1016/j.mib.2021.03.007
|View full text |Cite
|
Sign up to set email alerts
|

Targeting a highly conserved domain in bacterial histidine kinases to generate inhibitors with broad spectrum activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 24 publications
(17 citation statements)
references
References 66 publications
0
14
0
Order By: Relevance
“…One potential pitfall is that eukaryotic kinases may have biochemical or structural features that are similar to mycobacterial SKs. For instance, the ATP‐binding Bergerat fold present in SK CA domains is also found in several mammalian proteins, namely those of the GHKL (gyrase, Hsp90, histidine kinase, MutL) family (Bem et al, 2015; Fihn & Carlson, 2021). In this case, targeting the CA domain could be accompanied by the off‐target risk of host cytotoxicity.…”
Section: Discovery Of Inhibitors Of Two‐component Systemsmentioning
confidence: 99%
“…One potential pitfall is that eukaryotic kinases may have biochemical or structural features that are similar to mycobacterial SKs. For instance, the ATP‐binding Bergerat fold present in SK CA domains is also found in several mammalian proteins, namely those of the GHKL (gyrase, Hsp90, histidine kinase, MutL) family (Bem et al, 2015; Fihn & Carlson, 2021). In this case, targeting the CA domain could be accompanied by the off‐target risk of host cytotoxicity.…”
Section: Discovery Of Inhibitors Of Two‐component Systemsmentioning
confidence: 99%
“…In addition, histidine kinases (HK) were included as a target in the search for antibacterials [ 194 , 195 , 196 ]. HK are membrane receptors, which control a variety of cellular responses (e.g., virulence, secretion systems and antibiotic resistance).…”
Section: Secondary Screening: Target-based Assaysmentioning
confidence: 99%
“…It is, therefore, reasonable to assume that an HK inhibitor targeting multiple HKs could represent an innovative antivirulence drug against pathogenic bacteria [ 133 ]. Indeed, to identify molecules with broad anti-HK activity, Wilke et al [ 134 ] targeted the ATP-binding domain (CA) of HKs and performed high-throughput screening of 53,000 diverse small molecules, but the most potent compounds proved cytotoxic [ 134 , 135 ]. Other studies led to the identification of an HK inhibitor, waldiomycin, able to bind to the Hbox region commonly conserved in the DHp domain of HKs [ 136 ].…”
Section: Prospects: Drug Discovery Targeting Tcs Networkmentioning
confidence: 99%